Compagnie Lombard Odier SCmA’s Bausch Health BHC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,446
| Closed | -$9.37K | – | 455 |
|
|
2025
Q1 | $9.37K | Buy |
+1,446
| New | +$10.4K | ﹤0.01% | 428 |
|
|
2024
Q1 | – | Sell |
-1,446
| Closed | -$11.7K | – | 500 |
|
|
2023
Q4 | $11.7K | Hold |
1,446
| – | – | ﹤0.01% | 485 |
|
|
2023
Q3 | $12K | Buy |
+1,446
| New | +$12.5K | ﹤0.01% | 509 |
|
|
2023
Q2 | – | Sell |
-1,446
| Closed | -$11.7K | – | 605 |
|
|
2023
Q1 | $11.7K | Hold |
1,446
| – | – | ﹤0.01% | 544 |
|
|
2022
Q4 | $9K | Hold |
1,446
| – | – | ﹤0.01% | 611 |
|
|
2022
Q3 | $10K | Hold |
1,446
| – | – | ﹤0.01% | 571 |
|
|
2022
Q2 | $12K | Hold |
1,446
| – | – | ﹤0.01% | 537 |
|
|
2022
Q1 | $33K | Hold |
1,446
| – | – | ﹤0.01% | 487 |
|
|
2021
Q4 | $40K | Hold |
1,446
| – | – | ﹤0.01% | 524 |
|
|
2021
Q3 | $40K | Hold |
1,446
| – | – | ﹤0.01% | 519 |
|
|
2021
Q2 | $42K | Hold |
1,446
| – | – | ﹤0.01% | 505 |
|
|
2021
Q1 | $46K | Hold |
1,446
| – | – | ﹤0.01% | 516 |
|
|
2020
Q4 | $30K | Hold |
1,446
| – | – | ﹤0.01% | 481 |
|
|
2020
Q3 | $22K | Hold |
1,446
| – | – | ﹤0.01% | 448 |
|
|
2020
Q2 | $26K | Hold |
1,446
| – | – | ﹤0.01% | 436 |
|
|
2020
Q1 | $22K | Hold |
1,446
| – | – | ﹤0.01% | 400 |
|
|
2019
Q4 | $43K | Hold |
1,446
| – | – | ﹤0.01% | 366 |
|
|
2019
Q3 | $32K | Hold |
1,446
| – | – | ﹤0.01% | 389 |
|
|
2019
Q2 | $37K | Hold |
1,446
| – | – | ﹤0.01% | 379 |
|
|
2019
Q1 | $36K | Hold |
1,446
| – | – | ﹤0.01% | 424 |
|
|
2018
Q4 | $27K | Hold |
1,446
| – | – | ﹤0.01% | 430 |
|
|
2018
Q3 | $37K | Hold |
1,446
| – | – | ﹤0.01% | 450 |
|
|
2018
Q2 | $34K | Sell |
1,446
-100,000
| -99% | -$2.07M | ﹤0.01% | 474 |
|
|
2018
Q1 | $1.61M | Sell |
101,446
-101,446
| -50% | -$1.89M | 0.06% | 148 |
|
|
2017
Q4 | $4.22M | Buy |
202,892
+101,446
| +100% | +$1.61M | 0.08% | 141 |
|
|
2017
Q3 | $1.45M | Hold |
101,446
| – | – | 0.05% | 189 |
|
|
2017
Q2 | $1.75M | Buy |
101,446
+75,975
| +298% | +$911K | 0.06% | 182 |
|
|
2017
Q1 | $281K | Hold |
25,471
| – | – | 0.01% | 333 |
|
|
2016
Q4 | $370K | Sell |
25,471
-12,875
| -34% | -$236K | 0.01% | 367 |
|
|
2016
Q3 | $941K | Sell |
38,346
-36,900
| -49% | -$955K | 0.03% | 279 |
|
|
2016
Q2 | $1.51M | Buy |
75,246
+70,246
| +1,405% | +$1.99M | 0.04% | 223 |
|
|
2016
Q1 | $132K | Sell |
5,000
-1,000
| -17% | -$74K | ﹤0.01% | 565 |
|
|
2015
Q4 | $607K | Buy |
+6,000
| New | +$674K | 0.02% | 292 |
|
|
2015
Q3 | – | Sell |
-9,190
| Closed | -$2.04M | – | 813 |
|
|
2015
Q2 | $2.04M | Buy |
9,190
+7,461
| +432% | +$1.65M | 0.08% | 166 |
|
|
2015
Q1 | $342K | Sell |
1,729
-4,013
| -70% | -$712K | 0.01% | 375 |
|
|
2014
Q4 | $825K | Buy |
5,742
+279
| +5% | +$37.5K | 0.04% | 211 |
|
|
2014
Q3 | $717K | Sell |
5,463
-175
| -3% | -$20.9K | 0.03% | 244 |
|
|
2014
Q2 | $714K | Sell |
5,638
-1,392
| -20% | -$178K | 0.03% | 245 |
|
|
2014
Q1 | $926K | Sell |
7,030
-5,269
| -43% | -$720K | 0.04% | 213 |
|
|
2013
Q4 | $1.44M | Buy |
+12,299
| New | +$1.35M | 0.06% | 160 |
|
Other funds holding BHC
IC
GAM
PC
MRCP
Compagnie Lombard Odier SCmA's BHC Position: Q2 2025 in Review
Compagnie Lombard Odier SCmA sold out of Bausch Health (BHC) in Q2 2025, closing a stake of 1,446 shares — an estimated $9.37K sold.
Compagnie Lombard Odier SCmA first reported a position in BHC in Q4 2013 and held it in 40 quarters. The position peaked at $4.22M in Q4 2017. 212 funds tracked by Wall St. Rank hold BHC as of Q2 2025.
- Compagnie Lombard Odier SCmA reported no remaining Bausch Health position as of Q2 2025 after selling out during the quarter.
- Compagnie Lombard Odier SCmA sold 1,446 Bausch Health shares in Q2 2025, an estimated $9.37K.
- Compagnie Lombard Odier SCmA first reported a position in Bausch Health in Q4 2013 and held it in 40 quarters.
- Compagnie Lombard Odier SCmA's Bausch Health position peaked at $4.22M in Q4 2017.
- 212 funds tracked by Wall St. Rank held Bausch Health as of Q2 2025.
Based on Compagnie Lombard Odier SCmA's 13F filing for Q2 2025, filed 15 Jul 2025.